Amylocaine

Amylocaine

SCHEMBL81360

CCC(C)(CN(C)C)OC(=O)c1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 1.00
CYP1A2 P05177 1/20 1.00
CYP2C19 P33261 1/20 1.00
TDP1 Q9NUW8 4/20 0.44
TSHR P16473 3/20 0.44
LMNA P02545 2/20 0.44
ALDH1A1 P00352 2/20 0.44
HSD17B10 Q99714 1/20 0.44
HTR1A P08908 1/20 0.41
SCN1A P35498 1/20 0.41
SLC6A3 Q01959 1/20 0.41
SCN5A Q14524 1/20 0.41
SCN2A Q99250 1/20 0.41
SCN3A Q9NY46 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MAPK1 P28482 1/20 0.41
HIF1A Q16665 1/20 0.41
F2 P00734 1/20 0.40
KMT2A Q03164 2/20 0.40
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Amylocaine SCHEMBL81361 1.00 CYP2D6 (1.00) CYP2D6CYP1A2CYP2C19TDP1TSHR
Amylocaine SCHEMBL25684 0.98 CYP2D6 (0.97) CYP2D6CYP1A2CYP2C19TDP1TSHR
Amylocaine SCHEMBL25686 0.98 CYP2D6 (0.97) CYP2D6CYP1A2CYP2C19TDP1TSHR
Amylocaine SCHEMBL1648490 0.97 CYP2D6 (0.94) CYP2D6CYP1A2CYP2C19TDP1TSHR
SCHEMBL13514895 0.87 CYP2D6 (0.76) CYP2D6CYP1A2CYP2C19TDP1TSHR
SCHEMBL1783308 0.83 CYP2D6 (0.71) CYP2D6CYP1A2CYP2C19TDP1TSHR
SCHEMBL29351583 0.83 CYP2D6 (0.70) CYP2D6CYP1A2CYP2C19TDP1TSHR
SCHEMBL27692599 0.82 CYP2D6 (0.69) CYP2D6CYP1A2CYP2C19TDP1TSHR
SCHEMBL28684600 0.82 CYP2D6 (0.69) CYP2D6CYP1A2CYP2C19TDP1TSHR
SCHEMBL4576579 0.79 CYP2D6 (0.66) CYP2D6CYP1A2CYP2C19TDP1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2134 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260144801-A1 COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING MUSCLE CONDITIONS THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2026-05-28 US claimed
US-20260115156-A1 INJECTABLE COMPOSITION INCLUDING HYDROGEL CONTAINING ANESTHETIC AGENT UNIV KOREA RES & BUS FOUND (KR) 2026-04-30 US claimed
EP-4436552-B1 GASTRO-RETENTIVE ORAL DOSAGE UNIT CONTAINING A LOCAL ANAESTHETIC OREXA B V (NL) 2026-02-04 EP claimed
WO-2025235864-A1 COATED NEEDLE ADMINISTRATION SYSTEMS EVOLUS, INC. (US) 2025-11-13 WO claimed
US-20250332183-A1 COMPOSITIONS AND METHODS FOR THE STIMULATION OF INTERMEDIATE MACROPHAGES AND TREATMENTS THEREWITH AYUVIS RESEARCH, INC. 2025-10-30 US claimed
US-20250319025-A9 COMPOSITIONS COMPRISING MODIFIED PHOSPHOLIPIDS AND USES THEREOF THE CHILDREN'S MEDICAL CENTER CORPORATION (US) 2025-10-16 US claimed
US-12419619-B2 Aspiration device YALE UNIVERSITY (US) 2025-09-23 US claimed
EP-4578441-A1 TREATMENT OF LOCALIZED PAIN PlantTec Medical GmbH (DE) 2025-07-02 EP claimed
US-20250205278-A1 METHODS AND COMPOSITIONS FOR WOUND HEALING ABBOTT NICHOLAS L (US) 2025-06-26 US claimed
WO-2025128639-A1 HYDROGELS COMPRISING PROTEIN-STABILIZED NANOPARTICLES FOR EXTENDED RELEASE THE CHILDREN'S MEDICAL CENTER CORPORATION (US) 2025-06-19 WO claimed
US-20010055607-A1 COMPOSITIONS, KITS, AND METHODS FOR INHIBITING CEREBRAL NEUROVASCULAR DISORDERS AND MUSCULAR HEADACHES BHL PATENT HOLDINGS LLC 2001-12-27 US claimed
US-6297290-B2 INTENDED TO ANESTHETIZE THE SKIN OR THE MUCOUS MEMBRANES OR TO TREAT PRURITUS. CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOQUES GALDERMA (C.I.R.D. GALDERMA) (FR) 2001-10-02 US claimed
WO-2001043733-A2 COMPOSITIONS, KITS, APPARATUS, AND METHODS FOR INHIBITING CEPHALIC INFLAMMATION LEVIN BRUCE H (US) 2001-06-21 WO claimed
US-20010004644-A1 Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation LEVIN BRUCE H (US) 2001-06-21 US claimed
EP-1073470-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS INPHARMA S.A. (CH) 2001-02-07 EP claimed
WO-2000048636-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS INPHARMA S.A. (CH) 2000-08-24 WO claimed
EP-0494297-B1 GALENICAL PREPARATION METHOD FOR PREPARING A THERAPEUTICAL COMPOSITION PARTICULARLY BASED ON ASPIRIN PEROVITCH PHILIPPE (FR) 1995-10-18 EP claimed
EP-0494297-A1 GALENICAL PREPARATION METHOD FOR PREPARING A THERAPEUTICAL COMPOSITION PARTICULARLY BASED ON ASPIRIN. PEROVITCH PHILIPPE (FR) 1992-07-15 EP claimed
WO-1992001444-A1 GALENICAL PREPARATION METHOD FOR PREPARING A THERAPEUTICAL COMPOSITION PARTICULARLY BASED ON ASPIRIN PEROVITCH PHILIPPE (FR) 1992-02-06 WO claimed
EP-0468121-A1 Process for the galenical preparation of a therapeutic composition, in particular based on aspirin Perovitch, Philippe (FR) 1992-01-29 EP claimed